Advocating for a cure for Herpes Simplex Virus.
Alexander Birkmann, PhD, is a seasoned pharmaceutical professional with over 20 years of experience in antiviral drug development. He has held key positions at Bayer and AiCuris, contributing to theContinue reading "AiCuris: Dr. Alex Birkmann on Antiviral Drug Development for HSV"
Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccineContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
Despite the fact that 48% of people between 14 and 49 in the US are infected with HSV 1, and one in eight adults is infected with HSV-2, many peopleContinue reading "How Clinicians and Patients Talk about Herpes: Bridging the Disconnect"